Published 2 hours ago • loading... • Updated 2 hours ago

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

The big story today with Eli Lilly is its hugely successful GLP-1 drugs, but the long-term story is likely to be about its acquisitions.

1 Articles

The Motley Fool

Lean Left

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

The big story today with Eli Lilly is its hugely successful GLP-1 drugs, but the long-term story is likely to be about its acquisitions.

2 hours ago·Alexandria, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated56 minutes agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States 2 hours ago on Monday, September 7, 2026.

Sources are mostly out of (0)

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

1 Articles

1 Articles

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Semaglutide Linked to 20% Fewer COPD Flare-Ups and Nearly 40% Fewer Asthma Attacks

Novo Nordisk says semaglutide cut obesity rates in young children in trial

Weight-loss medicines and hair loss: New study finds genetic link in men

A Medicine for Weakness Has Reached the Black Market, Even if It Has Not Been Approved.

Socialism 2026 Speaker Slams Diet Industry for Policing ‘Black Fat Flesh,’ Calls It ‘Body Fascism’

Oprah Winfrey, 72, shows off slim figure at Telluride Film Festival

Similar News Topics

Similar News Topics

More stories like this

Semaglutide Linked to 20% Fewer COPD Flare-Ups and Nearly 40% Fewer Asthma Attacks

Novo Nordisk says semaglutide cut obesity rates in young children in trial

Weight-loss medicines and hair loss: New study finds genetic link in men

A Medicine for Weakness Has Reached the Black Market, Even if It Has Not Been Approved.

Socialism 2026 Speaker Slams Diet Industry for Policing ‘Black Fat Flesh,’ Calls It ‘Body Fascism’

Oprah Winfrey, 72, shows off slim figure at Telluride Film Festival

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

1 Articles

1 Articles

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Semaglutide Linked to 20% Fewer COPD Flare-Ups and Nearly 40% Fewer Asthma Attacks

Novo Nordisk says semaglutide cut obesity rates in young children in trial

Weight-loss medicines and hair loss: New study finds genetic link in men

A Medicine for Weakness Has Reached the Black Market, Even if It Has Not Been Approved.

Socialism 2026 Speaker Slams Diet Industry for Policing ‘Black Fat Flesh,’ Calls It ‘Body Fascism’

Oprah Winfrey, 72, shows off slim figure at Telluride Film Festival

Similar News Topics

Similar News Topics

More stories like this

Semaglutide Linked to 20% Fewer COPD Flare-Ups and Nearly 40% Fewer Asthma Attacks

Novo Nordisk says semaglutide cut obesity rates in young children in trial

Weight-loss medicines and hair loss: New study finds genetic link in men

A Medicine for Weakness Has Reached the Black Market, Even if It Has Not Been Approved.

Socialism 2026 Speaker Slams Diet Industry for Policing ‘Black Fat Flesh,’ Calls It ‘Body Fascism’

Oprah Winfrey, 72, shows off slim figure at Telluride Film Festival

Bias Distribution

Factuality